Motus GI Holdings, Inc. (NASDAQ:MOTS – Get Free Report)’s stock price rose 16% during mid-day trading on Monday . The company traded as high as $4.30 and last traded at $4.27. Approximately 80,263 shares were traded during mid-day trading, an increase of 104% from the average daily volume of 39,368 shares. The stock had previously closed at $3.68.
Analysts Set New Price Targets
MOTS has been the subject of a number of analyst reports. HC Wainwright reissued a “buy” rating and issued a $37.50 price target on shares of Motus GI in a report on Wednesday, September 27th. Alliance Global Partners decreased their price target on Motus GI from $24.75 to $20.25 in a report on Thursday, August 17th.
Motus GI Trading Up 16.0 %
Institutional Trading of Motus GI
Large investors have recently added to or reduced their stakes in the stock. Virtu Financial LLC purchased a new stake in Motus GI in the 2nd quarter valued at $56,000. Renaissance Technologies LLC grew its holdings in shares of Motus GI by 73.5% during the 2nd quarter. Renaissance Technologies LLC now owns 127,500 shares of the company’s stock worth $36,000 after purchasing an additional 54,000 shares during the period. Millennium Management LLC grew its holdings in shares of Motus GI by 237.7% during the 2nd quarter. Millennium Management LLC now owns 114,987 shares of the company’s stock worth $32,000 after purchasing an additional 80,938 shares during the period. Finally, Armistice Capital LLC grew its holdings in shares of Motus GI by 107.7% during the 3rd quarter. Armistice Capital LLC now owns 567,000 shares of the company’s stock worth $255,000 after purchasing an additional 294,012 shares during the period. 8.61% of the stock is currently owned by hedge funds and other institutional investors.
Motus GI Company Profile
Motus GI Holdings, Inc operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp.
- Five stocks we like better than Motus GI
- Pros And Cons Of Monthly Dividend Stocks
- The most upgraded stocks in November have two things in common
- How to Invest in Semiconductors
- Monday.com rocked earnings like it’s the weekend
- The How and Why of Investing in Gold Stocks
- Plan to own one retailer? Make it this one
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.